Page 637 - Williams Hematology ( PDFDrive )

612 Part VI: The Erythrocyte Chapter 41: Folate, Cobalamin, and Megaloblastic Anemias 613

231. Afman L, Van Der Put N, Thomas C, et al: Reduced vitamin B12 binding by transcobal- 263. Suri-Payer E, Kehn P, Cheever A, Shevach E: Pathogenesis of post-thymectomy auto-
amin II increases the risk of neural tube defects. QJM 94(3):159–166, 2001. immune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells.
232. Thompson M, Cole D, Ray J: Vitamin B-12 and neural tube defects: The Canadian expe- J Immunol 157(4):1799–1805, 1996.
rience. Am J Clin Nutr 89(2):697S–701S, 2009. 264. Kapadia C, Donaldson RJ: Disorders of cobalamin (vitamin B12) absorption and trans-
233. Ramos MI, Allen LH, Haan MN, et al: Plasma folate concentrations are associated with port. Annu Rev Med 36:93–110, 1985.
depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin 265. Chanarin I, James D: Humoral and cell-mediated intrinsic-factor antibody in perni-
Nutr 80(4):1024–1028, 2004. cious anaemia. Lancet 1(7866):1078–1080, 1974.
234. D’Angelo A, Selhub J: Homocysteine and thrombotic disease. Blood 90(1):1–11, 1997. 266. Conn H, Binder H, Burns B: Pernicious anemia and immunologic deficiency. Ann
235. Schnyder G, Roffi M, Pin R, et al: Decreased rate of coronary restenosis after lowering Intern Med 68(3):603–612, 1968.
of plasma homocysteine levels. N Engl J Med 345(22):1593–1600, 2001. 267. Conn HO, Binder H, Burns B: Pernicious anemia and immunologic deficiency. Ann
236. Lange H, Suryapranata H, De Luca G, et al: Folate therapy and in-stent restenosis after Intern Med 68(3):603–612, 1968.
coronary stenting. N Engl J Med 350(26):2673–2681, 2004. 268. Ardeman S, Chanarin I, Krafchik B, Singer W: Addisonian pernicious anaemia and
237. Bonaa KH, Njolstad I, Ueland PM, et al: Homocysteine lowering and cardiovascular intrinsic factor antibodies in thyroid disorders. Q J Med 35(139):421–431, 1966.
events after acute myocardial infarction. N Engl J Med 354(15):1578–1588, 2006. 269. Comin D, Hines J, Wieland R: Coexistent pernicious anemia and idiopathic hypopara-
238. Yang Q, Botto LD, Erickson JD, et al: Improvement in stroke mortality in Canada and thyroidism in a women. JAMA 207(6):1147–1149, 1969.
the United States, 1990 to 2002. Circulation 113(10):1335–1343, 2006. 270. Mazzone T, Kelly W, Ensinck J: Lymphocytic hypophysitis. Associated with antiparietal
239. Clarke R, Halsey J, Lewington S, et al: Effects of lowering homocysteine levels with B cell antibodies and vitamin B12 deficiency. Arch Intern Med 143(9):1794–1795, 1983.
vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis 271. Howitz J, Schwartz M: Vitiligo, achlorhydria, and pernicious anaemia. Lancet 1(7713):
of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170(18):1622– 1331–1334, 1971.
1631, 2010. 272. Jackson I, Doig W, McDonald G: Pernicious anaemia as a cause of infertility. Lancet
240. Seshadri S, Beiser A, Selhub J, et al: Plasma homocysteine as a risk factor for dementia 2(7527):1159–1160, 1967.
and Alzheimer’s disease. N Engl J Med 346(7):476–483, 2002. 273. Watson A: Seminal vitamin B12 and sterility. Lancet 2(7257):644, 1962.
241. Haan MN, Miller JW, Aiello AE, et al: Homocysteine, B vitamins, and the incidence of 274. Pront R, Margalioth EJ, Green R, et al: Prevalence of low serum cobalamin in infertile
dementia and cognitive impairment: Results from the Sacramento Area Latino Study couples. Andrologia 2009;41(1):46–50, 1962.
on Aging. Am J Clin Nutr 85(2):511–517, 2007. 275. Ungar B, Mathews J, Tait B, Cowling D: HLA-DR patterns in pernicious anaemia. Br
242. Kluijtmans L, Young I, Boreham C, et al: Genetic and nutritional factors contributing to Med J (Clin Res Ed) 282(6266):768–770, 1981.
hyperhomocysteinemia in young adults. Blood 101(7):2483–2488, 2003. 276. Hoskins L, Loux H, Britten A, Zamcheck N: Distribution of ABO blood groups in
243. Quinlivan E, McPartlin J, McNulty H, et al: Importance of both folic acid and vitamin patients with pernicious anemia, gastric carcinoma and gastric carcinoma associated
B12 in reduction of risk of vascular disease. Lancet 359(9302):227–228, 2002. with pernicious anemia. N Engl J Med 273(12):633–637, 1965.
244. Lievers K, Kluijtmans L, Boers G, et al: Influence of a glutamate carboxypeptidase 277. Wangel A, Callender S, Spray G, Wright R: A famiy study of pernicious anaemia. I.
II (GCPII) polymorphism (1561C—>T) on plasma homocysteine, folate and vita- Autoantibodies, achlorhydria, serum pepsinogen and vitamin B12. Br J Haematol
min B(12) levels and its relationship to cardiovascular disease risk. Atherosclerosis 14(2):161–181, 1968.
164(2):269–273, 2002. 278. Varis K, Ihamäki T, Härkönen M, et al: Gastric morphology, function, and immunology
245. Walker S, Wein P, Ihle B: Severe folate deficiency masquerading as the syndrome of in first-degree relatives of probands with pernicious anemia and controls. Scand J Gas-
hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol 90(4 Pt 2):655–657, troenterol 14(2):129–139, 1979.
1997. 279. Eriksson S, Clase L, Moquist-Olsson I: Pernicious anemia as a risk factor in gastric
246. Hartong SC, Steegers EA, Visser W: Hemolysis, elevated liver enzymes and low plate- cancer. The extent of the problem. Acta Med Scand 210(6):481–484, 1981.
lets during pregnancy due to Vitamin B12 and folate deficiencies. Eur J Obstet Gynecol 280. Savage D, Gangaidzo I, Lindenbaum J, et al: Vitamin B12 deficiency is the primary
Reprod Biol 131(2):241–242, 2007. cause of megaloblastic anaemia in Zimbabwe. Br J Haematol 86(4):844–850, 1994.
247. Giovannucci E, Stampfer M, Colditz G, et al: Multivitamin use, folate, and colon cancer 281. Wilkinson JF: The gastric secretions in pernicious anemia. Q J Med 1(3)361, 1932.
in women in the Nurses’ Health Study. Ann Intern Med 129(7):517–524, 1998. 282. Karnes WJ, Samloff I, Siurala M, et al: Positive serum antibody and negative tissue
248. Ma J, Stampfer M, Giovannucci E, et al: Methylenetetrahydrofolate reductase polymor- staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterol-
phism, dietary interactions, and risk of colorectal cancer. Cancer Res 57(6):1098–1102, ogy 101(1):167–174, 1991.
1997. 283. Green R: Protean H. pylori: Perhaps “pernicious” too? (Editorial) Blood 107(4):1247,
249. Mason JB, Dickstein A, Jacques PF, et al: A temporal association between folic acid for- 2006.
tification and an increase in colorectal cancer rates may be illuminating important bio- 284. Slingerland D, Cardarelli J, Burrows B, Miller A: The utility of serum gastrin levels in
logical principles: A hypothesis. Cancer Epidemiol Biomarkers Prev 16(7):1325–1329, assessing the significance of low serum B12 levels. Arch Intern Med 144(6):1167–1168,
2007. 1984.
250. Kim Y: Will mandatory folic acid fortification prevent or promote cancer? Am J Clin 285. Ganguli P, Cullen D, Irvine W: Radioimmunoassay of plasma gastrin in pernicious
Nutr 80(5):1123–1128, 2004. anaemia, achlorhydria without pernicious anaemia, hypochlorhydria, and in controls.
251. Vollset SE, Clarke R, Lewington S, et al: Effects of folic acid supplementation on overall Lancet 1(7691):155–158, 1971.
and site-specific cancer incidence during the randomised trials: Meta-analyses of data 286. Kaye M, Whorwell P, Wright R: Gastric mucosal lymphocyte subpopulations in per-
on 50,000 individuals. Lancet 381(9871):1029–1036, 2013. nicious anemia and in normal stomach. Clin Immunol Immunopathol 28(3):431–440,
252. Rosenberg I: Folic acid and neural-tube defects—Time for action? N Engl J Med 1983.
327(26):1875–1877, 1992. 287. Rodbro P, Dige-Petersen H, Schwartz M, Dalgaard O: Effect of steroids on gastric
253. Hibbard E, Spencer W: Low serum B12 levels and latent Addisonian anaemia in preg- mucosal structure and function in pernicious anemia. Acta Med Scand 181(4):445–452,
nancy. J Obstet Gynaecol Br Commonw 77(1):52–57, 1970. 1967.
254. Carmel R, Johnson C: Racial patterns in pernicious anemia. Early age at onset and 288. Ransohoff R, Jacobsen D, Green R: Vitamin B12 deficiency and multiple sclerosis. Lan-
increased frequency of intrinsic-factor antibody in black women. N Engl J Med cet 335(8700):1285–1286, 1990.
298(12):647–650, 1978. 289. Nieburgs H, Glass G: Gastric-cell maturation disorders in atrophic gastritis, pernicious
255. Vilter CF, Vilter RW, Spies TD: The treatment of pernicious and related anemias with anemia, and carcinoma. Histologic site of origin and diagnostic significance of abnor-
synthetic folic acid: I. Observations on the maintenance of a normal hematologic status mal cells. Am J Dig Dis 8:135–159, 1963.
and on the occurrence of combined system disease at the end of one year. J Lab Clin 290. Foroozan P, Trier J: Mucosa of the small intestine in pernicious anemia. N Engl J Med
Med 32(3):262–273, 1947. 277(11):553–559, 1967.
256. Andersen L, Hansen E, Knudsen J, et al: Prospectively measured red cell folate levels 291. Bezman A, Kinnear D, Zamcheck N: D-Xylose and potassium iodide absorption and
in methotrexate treated patients with rheumatoid arthritis: Relation to withdrawal and serum carotene in pernicious anemia. J Lab Clin Med 53(2):226–232, 1959.
side effects. J Rheumatol 24(5):830–837, 1997. 292. Ellison A: Pernicious anemia masked by multivitamins containing folic acid. JAMA
257. Kim YS, Sun JM, Ahn JS, et al: The optimal duration of vitamin supplementation prior 173:240–243, 1960.
to the first dose of pemetrexed in patients with non-small-cell lung cancer. Lung Cancer 293. Carmel R: Subtle and atypical cobalamin deficiency states. Am J Hematol 34(2):108–
81(2):231–235, 2013. 114, 1990.
258. Stabler SP: Clinical practice. Vitamin B12 deficiency. N Engl J Med 368(2):149–160, 294. Lindenbaum J, Healton E, Savage D, et al: Neuropsychiatric disorders caused by cobal-
2013. amin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318(26):1720–
259. Toh B, van Driel I, Gleeson P: Pernicious anemia. N Engl J Med 337(20):1441–1448, 1728, 1988.
1997. 295. MacLean L, Sundberg R: Incidence of megaloblastic anemia after total gastrectomy. N
260. Kano Y, Sakamoto S, Miura Y, Takaku F: Disorders of cobalamin metabolism. Crit Rev Engl J Med 254(19):885–893, 1956.
Oncol Hematol 3(1):1–34, 1985. 296. Gozzard D, Dawson D, Lewis M: Experiences with dual protein bound aqueous vita-
261. Irvine W, Davies S, Teitelbaum S, et al: The clinical and pathological significance of min B12 absorption test in subjects with low serum vitamin B12 concentrations. J Clin
gastric parietal cell antibody. Ann N Y Acad Sci 124(2):657–691, 1965. Pathol 40(6):633–637, 1987.
262. Gaarder P, Heier H: A human autoantibody to renal collecting duct cells associated 297. Van der Weyden M, Rother M, Firkin B: Megaloblastic maturation masked by iron
with thyroid and gastric autoimmunity and possibly renal tubular acidosis. Clin Exp deficiency: A biochemical basis. Br J Haematol 22(3):299–307, 1972.
Immunol 51(1):29–37, 1983.

Kaushansky_chapter 41_p0583-0616.indd 612 9/17/15 6:24 PM